Universal Infectious Disease Assay Facilitated by CRISPR Mediated Depletion - Jumpcode Genomics

Jon Armstrong - Vice President, Research & Development at Jumpcode Genomics

Comparative performance of NGS platforms in a novel universal infectious disease assay
AVITI™ highly concordant in identifying all COVID samples tested regardless of Ct value
AVITI highly concordant in identifying all 49 non-human organisms tested

Download App Note

Leave this field blank

Contact Sales

Agriculture ResearchAnimal TestingApplied MicrobiologyAutoimmune Disease ResearchCancer ResearchCardiovascular Disease ResearchCell and Molecular Biology ResearchClinical OncologyConsumer GenomicsGenetic and Complex Disease ResearchGenetic HealthHealthy ScreeningMetabolic Disease ResearchMicrobiology/Virology ResearchNeuroscience ResearchNIPTPharmacogenomics PGxPlant TestingPreconception and FertilityPublic HealthRare and Inherited Disease

By submitting this form you agree to our Privacy Policy and Terms and Conditions.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Where freedom drives discovery

Headquarters

10055 Barnes Canyon Road Suite 100 San Diego, CA 92121

Get In Touch

Connect

Twitter LinkedIn

We're Hiring